| Literature DB >> 28410161 |
Ellen Kilsdonk1, Eline van Dulmen-den Broeder2, Helena J van der Pal3, Nynke Hollema4, Leontien C Kremer5, Marry M van den Heuvel-Eibrink6, Flora E van Leeuwen7, Monique W Jaspers1, Marleen H van den Berg2.
Abstract
BACKGROUND: Questionnaires are widely used in survey research, especially in cohort studies. However, participation in questionnaire studies has been declining over the past decades. Because high participation rates are needed to limit the risk of selection bias and produce valid results, it is important to investigate invitation strategies which may improve participation.Entities:
Keywords: childhood cancer survivors; follow-up strategies; participation rates; questionnaire mode; questionnaires
Year: 2015 PMID: 28410161 PMCID: PMC5367669 DOI: 10.2196/cancer.3905
Source DB: PubMed Journal: JMIR Cancer ISSN: 2369-1999
Study arms.
|
| Study arm 1 | Study arm 2 | Study arm 3 |
| Initial invitation | Web-based questionnaire | Web-based questionnaire | Web- and paper-based questionnaire |
| First reminder (after 3 weeks, in case of no response to initial contact) | Web-based questionnaire | Web- and paper-based questionnaire | Web based and option to apply for new paper-based questionnaire |
| Second reminder (after 3 weeks, in case of no response to 1st reminder) | Web- and paper-based questionnaire | Web-based and option to apply for new paper-based questionnaire | Telephone contact |
| Third reminder | Telephone contact | Telephone contact |
Sociodemographic and treatment-related characteristics of the CCSs in each study arm.
| Characteristic | Study arm 1 | Study arm 2 | Study arm 3 | |
| Number of survivors, n |
| 249 | 251 | 250 |
| Median current age (years), range |
| 29 (18-58) | 30 (18-61) | 31 (18-60) |
| Median age at childhood cancer diagnosis (years), range |
| 6 (0-17) | 6 (0-17) | 6 (0-17) |
| Median time since diagnosis (years), range |
| 23 (10-46) | 23 (10-49) | 23 (10-49) |
|
|
|
|
|
|
|
| Male | 122 (49.0) | 127 (50.6) | 124 (49.6) |
|
| Female | 127 (51.0) | 124 (49.4) | 126 (50.4) |
|
|
|
|
|
|
|
| EKZ/AMC | 114 (45.8) | 111 (44.2) | 112 (44.8) |
|
| Erasmus MC | 80 (32.1) | 83 (33.1) | 82 (32.8) |
|
| VUmc | 55 (22.1) | 57 (22.7) | 56 (22.4) |
|
|
|
|
|
|
|
| Central nervous system tumor | 31 (12.5) | 38 (15.1) | 38 (15.2) |
|
| Leukemia | 77 (30.9) | 66 (26.3) | 58 (23.2) |
|
| Lymphoma | 41 (16.5) | 43 (17.2) | 48 (19.2) |
|
| Renal tumor | 27 (10.8) | 38 (15.1) | 32 (12.8) |
|
| Other | 73 (29.3) | 66 (26.3) | 74 (29.6) |
| Chemotherapy, n (%) |
| 199 (79.9) | 187 (74.5) | 191 (76.4) |
| Radiotherapy, n (%) |
| 95 (38.2) | 86 (34.3) | 98 (39.2) |
| Surgery, n (%) |
| 162 (65.1) | 176 (70.1) | 174 (69.6) |
| Other therapy, n (%) |
| 135 (54.2) | 129 (51.4) | 128 (51.2) |
| Recurrence of disease, n (%) |
| 39 (15.7) | 30 (12.0) | 31 (12.4) |
| Recent visit to late effect outpatient clinic (<2 years), n (%) |
| 87 (34.9) | 103 (41.0) | 98 (39.2) |
Figure 1Flow diagram of the study.
Reasons for declining to complete the questionnaire (N=140).
| Reasons | Telephone survey or refusal, n (%) |
| Unknown | 18 (12.9) |
| I do not want to be confronted with the past | 37 (26.4) |
| I have already participated in many studies | 34 (24.3) |
| I think the questionnaire is too long | 15 (10.7) |
| I have no time to fill out the questionnaire | 11 (7.9) |
| I have no interest in this study | 11 (7.9) |
| I have had bad experiences in the past with research/care | 6 (4.3) |
| I am currently unable to fill out the questionnaire | 5 (3.6) |
| The answers to the questions are already available at the clinic | 4 (2.9) |
| I am unable to answer the questions due to a mental handicap | 4 (2.9) |
| I find the information about the study unclear | 0 (0.0) |
Differences in participant characteristics between paper-based and web-based questionnaires.
|
|
| Paper-based questionnaire | Web-based questionnaire |
|
| Survivors, n |
| 196 | 240 |
|
| Median age, range |
| 30 (18-61) | 31 (18-57) | .73 |
| Median age at diagnosis, range |
| 6 (0-17) | 6 (0-17) | .88 |
| Median number of years since diagnosis, range |
| 23 (10-49) | 23 (11-45) | .52 |
|
|
|
|
| .96 |
|
| Male | 93 (47.4) | 109 (45.4) |
|
|
| Female | 103 (52.6) | 131 (54.6) |
|
|
|
|
|
|
|
|
| AMC | 104 (53.1) | 104 (43.3) |
|
|
| Erasmus | 50 (25.5) | 84 (35.0) |
|
|
| VUmc | 42 (21.4) | 52 (21.7) |
|
|
|
|
|
| .40 |
|
| Central nervous system tumor | 26 (13.3) | 24 (10.0) |
|
|
| Leukemia | 50 (25.5) | 57 (23.8) |
|
|
| Lymphoma | 39 (19.9) | 48 (20.0) |
|
|
| Renal tumor | 29 (14.8) | 38 (15.8) |
|
|
| Other | 52 (26.5) | 73 (30.4) |
|
| Chemotherapy, n (%) |
| 153 (78.1) | 192 (80.0) | .91 |
| Radiotherapy, n (%) |
| 81 (41.3) | 90 (37.5) | .40 |
| Surgery, n (%) |
| 133 (67.9) | 173 (72.1) | .73 |
| Other therapy, n (%) |
| 104 (53.1) | 124 (51.7) | .81 |
| Recurrence of disease, n (%) |
| 26 (13.3) | 33 (13.8) | .70 |
| Recent visit to late effect outpatient clinic (<2 years), n (%) |
| 92 (46.9) | 99 (41.2) | .76 |
|
|
|
|
| .28 |
|
| Single | 72 (36.7) | 77 (32.1) |
|
|
| In a relationship | 68 (34.7) | 85 (35.4) |
|
|
| (Ever) Married | 56 (28.6) | 78 (32.5) |
|
|
|
|
|
| .02 |
|
| Student | 29 (15.2) | 45 (18.8) | .83 |
|
| Employed | 122 (63.9) | 169 (70.7) | .24 |
|
| Unemployed | 40 (20.9) | 25 (10.5) | .015 |
|
| Unknown | 5 | 1 |
|
|
|
|
|
| .001 |
|
| Lowa | 35 (17.9) | 17 (7.1) | .008 |
|
| Mediumb | 107 (54.6) | 135 (56.2) | .67 |
|
| Highc | 54 (27.6) | 88 (36.7) | .04 |
aLow educational level: ISCED levels 0 to 2.
bMedium educational level: ISCED levels 3 to 5.
cHigh education level: ISCED levels 6 to 8.